Antibody technology

Antibodies are important tools for medical applications as well as for experimental research. The majority of antibodies are composed of two heavy chains and two light chains, where both chains contribute to the antigen-binding site. Camelids and sharks produce antibodies consisting only of heavy chains. This format shows a number of favorable properties. A further improvement of these molecules is achieved by a new antibody format – dimers of variable domains of the heavy chains.

Further Information: PDF

ESA Patentverwertungsagentur Sachsen-Anhalt GmbH
Phone: +49 (0)391/8 10 72 20

Contact
Dr. Stefan Schünemann

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

New Milestone in Quantum Research

Google Quantum AI and quantum physicists at Freie Universität Berlin publish groundbreaking results on Hamiltonian operators. A research team including researchers at Freie Universität Berlin and Google Quantum AI has…

Breakthrough in photonic time crystals

… could change how we use and control light. The new discovery could dramatically enhance technologies like lasers, sensors and optical computing in the near future. An international research team…

Custom Print Heads for 3D Printing

Achieving Individual Functional Integration. Wire or Fiber Encapsulating Additive Manufacturing (WEAM/FEAM) could significantly simplify the industrial production of components that require the integration of complex yet compact wiring, sensors, actuators,…